Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
---|---|---|---|---|---|---|
FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
SAMSRITA LABS LIMITED | NA | NA | NA | NA | 34.0 | |
TRANSGENE BIOTEK LTD. | NA | NA | NA | NA | 32.2 | |
Shree Ganesh Biotech (India) L | NA | NA | NA | NA | 31.1 | 66.2 |
SAMSRITA LABS LIMITED, with Security Code 539267, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.
Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Expenses | 0.1 | 0.8 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
Operating Profit | -0.1 | -0.8 | -0.1 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 |
OPM % | 0% | -3636.36% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Other Income | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit before tax | 0.0 | -0.7 | -0.1 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 |
Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Net Profit | 0.0 | -0.7 | -0.1 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | -0.1 |
EPS in Rs | -0.01 | -0.44 | -0.06 | -0.03 | -0.03 | -0.05 | -0.06 | -0.03 | -0.03 | 0 |
Metrics | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 |
---|---|---|---|---|---|---|---|---|---|---|
Sales | 0.4 | 0.4 | 0.4 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Expenses | 1.1 | 0.9 | 0.9 | 0.8 | 0.3 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 |
Operating Profit | -0.7 | -0.6 | -0.5 | -0.5 | -0.3 | -0.3 | -0.2 | -0.1 | -0.1 | -0.1 |
OPM % | -163.27% | -167.71% | -112.05% | -216.53% | -2338.46% | 0% | 0% | 0% | 0% | 0% |
Other Income | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit before tax | -0.7 | -0.5 | -0.4 | -0.5 | -0.3 | -0.3 | -0.2 | 0.0 | 0.0 | 0.0 |
Tax % | 0% | 0% | 0% | -14.8% | 0% | -3.2% | 0% | -83.3% | 0% | 0% |
Net Profit | -0.7 | -0.5 | -0.4 | -0.4 | -0.3 | -0.3 | -0.2 | 0.0 | 0.0 | 0.0 |
EPS in Rs | -0.42 | -0.36 | -0.28 | -0.26 | -0.19 | -0.19 | -0.13 | -0.09 | -0.03 | -0.02 |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 13% |
3 Years: | 0% |
TTM: | -4% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | -17% |
3 Years: | -6% |
1 Year: | 26% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 14% |
3 Years: | 18% |
TTM: | 63% |
Stock Price CAGR | |
---|---|
10 Years: | 0% |
5 Years: | -17% |
3 Years: | -6% |
1 Year: | 26% |
Recent Bets
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
---|
Period | SMA Value | Status |
---|
Period | EMA Value | Status |
---|
Indicator | Value |
---|